Tofacitinib citrate

Tofacitinib citrate

Tofacitinib (trade name Xeljanz, Jakvinus) is a janus kinase (JAK) inhibitor for the treatment of rheumatoid arthritis (RA). Tofacitinib has been approved by the U.S Food and Drug Administration in November 2012.

Specifications

Product Name:                  Tofacitinib citrate

Synonyms:                         CP-690550

CAS Number:                     540737-29-9

Molecular Weight:            504.4986

Molecular Formula:          C22H28N6O8

Purity (HPLC):                     ≥99%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               OC(=O)C(CC(=O)O)(CC(=O)O)O.N#CCC(=O)N1CC[C@H]([C@H](C1)N(c1ncnc2c1cc[nH]2)C)C

  • $415.00
  • Ex Tax: $415.00

Available Options